Leronlimab is a trial for locally advanced or metastatic cancer. Your tumor must be CCR5 positive. With this trial you can continue whatever treatment you are currently doing, side effects are little to none. And it's a simple injection.
https://www.clinicaltrials.gov/ct2/show/NCT04504942